San Diego-primarily based Viking Therapeutics marked alone as a serious competitor within the weight loss drug market in February immediately after revealing promising info from the mid-phase demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when given being a weekly injection and in March the c